Cover Image
市場調查報告書

Selecta Biosciences, Inc.:產品平台分析

Selecta Biosciences, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256107
出版日期 內容資訊 英文 31 Pages
訂單完成後即時交付
價格
Back to Top
Selecta Biosciences, Inc.:產品平台分析 Selecta Biosciences, Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 31 Pages
簡介

Selecta Biosciences, Inc.是開發奈米粒子免疫調節藥物的生物製藥公司,提供活用免疫調節奈米醫藥來引出抗原特異性免疫反應以預防疾病或治療的劃時代醫藥品。

本報告提供Selecta Biosciences, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Selecta Biosciences, Inc.的基本資料

  • Selecta Biosciences, Inc.概要
  • 主要資訊
  • 企業資料

Selecta Biosciences, Inc.:R&D概要

  • 主要的治療範圍

Selecta Biosciences, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Selecta Biosciences, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Selecta Biosciences, Inc.:藥物簡介

  • SEL-068
  • SEL-201
  • SEL-212
  • Vaccine for Food Allergy
  • Human Papillomavirus Vaccine Program
  • Malaria Vaccine
  • Vaccine for Head and Neck Cancer
  • Vaccine for Type 1 Diabetes

Selecta Biosciences, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型

Selecta Biosciences, Inc.:最近的開發平台趨勢

Selecta Biosciences, Inc.:暫停中的計劃

Selecta Biosciences, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07366CDB

Summary

Global Markets Direct's, 'Selecta Biosciences, Inc. - Product Pipeline Review - 2015', provides an overview of the Selecta Biosciences, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Selecta Biosciences, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Selecta Biosciences, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Selecta Biosciences, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Selecta Biosciences, Inc.'s pipeline products

Reasons to buy

  • Evaluate Selecta Biosciences, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Selecta Biosciences, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Selecta Biosciences, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Selecta Biosciences, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Selecta Biosciences, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Selecta Biosciences, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Selecta Biosciences, Inc. Snapshot
    • Selecta Biosciences, Inc. Overview
    • Key Information
    • Key Facts
  • Selecta Biosciences, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Selecta Biosciences, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Selecta Biosciences, Inc. - Pipeline Products Glance
    • Selecta Biosciences, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Selecta Biosciences, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Selecta Biosciences, Inc. - Drug Profiles
    • pegadricase
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SEL-068
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SEL-201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Food Allergy
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for HPV Associated Head and Neck Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Gene Therapy for Muscular Dystrophy and Liver Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • malarial vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Celiac Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Type 1 Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Selecta Biosciences, Inc. - Pipeline Analysis
    • Selecta Biosciences, Inc. - Pipeline Products by Target
    • Selecta Biosciences, Inc. - Pipeline Products by Route of Administration
    • Selecta Biosciences, Inc. - Pipeline Products by Molecule Type
  • Selecta Biosciences, Inc. - Recent Pipeline Updates
  • Selecta Biosciences, Inc. - Dormant Projects
  • Selecta Biosciences, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Selecta Biosciences, Inc., Key Information
  • Selecta Biosciences, Inc., Key Facts
  • Selecta Biosciences, Inc. - Pipeline by Indication, 2015
  • Selecta Biosciences, Inc. - Pipeline by Stage of Development, 2015
  • Selecta Biosciences, Inc. - Monotherapy Products in Pipeline, 2015
  • Selecta Biosciences, Inc. - Phase I, 2015
  • Selecta Biosciences, Inc. - Preclinical, 2015
  • Selecta Biosciences, Inc. - Discovery, 2015
  • Selecta Biosciences, Inc. - Pipeline by Target, 2015
  • Selecta Biosciences, Inc. - Pipeline by Route of Administration, 2015
  • Selecta Biosciences, Inc. - Pipeline by Molecule Type, 2015
  • Selecta Biosciences, Inc. - Recent Pipeline Updates, 2015
  • Selecta Biosciences, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Selecta Biosciences, Inc. - Pipeline by Top 10 Indication, 2015
  • Selecta Biosciences, Inc. - Pipeline by Stage of Development, 2015
  • Selecta Biosciences, Inc. - Monotherapy Products in Pipeline, 2015
  • Selecta Biosciences, Inc. - Pipeline by Top 10 Target, 2015
  • Selecta Biosciences, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top